Legal & General Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,573
| Closed | -$207K | – | 3541 |
|
|
2020
Q4 | $207K | Sell |
1,573
-49
| -3% | -$6.45K | ﹤0.01% | 2413 |
|
|
2020
Q3 | $82K | Sell |
1,622
-476
| -23% | -$24.1K | ﹤0.01% | 2544 |
|
|
2020
Q2 | $100K | Buy |
2,098
+10
| +0.5% | +$477 | ﹤0.01% | 2538 |
|
|
2020
Q1 | $102K | Sell |
2,088
-512
| -20% | -$25K | ﹤0.01% | 2405 |
|
|
2019
Q4 | $150K | Buy |
2,600
+704
| +37% | +$40.6K | ﹤0.01% | 2472 |
|
|
2019
Q3 | $68K | Hold |
1,896
| – | – | ﹤0.01% | 2642 |
|
|
2019
Q2 | $54K | Sell |
1,896
-800
| -30% | -$22.8K | ﹤0.01% | 2751 |
|
|
2019
Q1 | $63K | Buy |
2,696
+1,592
| +144% | +$37.2K | ﹤0.01% | 2638 |
|
|
2018
Q4 | $15K | Hold |
1,104
| – | – | ﹤0.01% | 3191 |
|
|
2018
Q3 | $11K | Buy |
+1,104
| New | +$11K | ﹤0.01% | 3319 |
|